Journal of Lipid Research, Vol 30, 831-840, Copyright © 1989 by Lipid Research, Inc.

ARTICLES

Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation

K Desai, KR Bruckdorfer, RA Hutton and JS Owen
Department of Medicine, Royal Free Hospital School of Medicine, University of London, Hampstead, United Kingdom.

High density lipoproteins (HDL, d 1.063-1.21 g/ml) are reported to stimulate, to have no effect on, or to inhibit agonist-induced platelet aggregation. We have hypothesized that these conflicting reports might be explained by opposing effects of individual HDL subclasses on platelet aggregability. Physiologic concentrations of HDL3 had little effect on ADP-induced aggregation of washed platelet suspensions, although higher levels were stimulatory. Normal concentrations of HDL2 (0.2-0.4 mg of protein/ml) inhibited aggregation; further fractionation by heparin-Sepharose chromatography identified the particles rich in apolipoprotein E, termed HDL-E, as the major anti-aggregatory subclass. Washed platelets bound radioiodinated HDL-E to a uniform class of saturable sites; they numbered 4,200 per platelet and the KD was 7.9 x 10(-7) M. Binding of HDL-E by platelets, and its anti-aggregatory action, showed a similar rapidity and both occurred within the physiologic concentration range. Moreover, the two processes were independent of the presence of divalent ions and were impaired by chemical modification of the apolipoprotein constituents of HDL-E. We conclude that occupation of cell-surface receptors by HDL-E particles impairs platelet responsiveness to exogenous agonists and that platelet aggregability in the presence of whole HDL may reflect the relative concentrations of the individual subclasses in the particular sample.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. M. deGoma, R. L. deGoma, and D. J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2199 - 2211. [Abstract] [Full Text] [PDF]

				M. Valiyaveettil, N. Kar, M. Z. Ashraf, T. V. Byzova, M. Febbraio, and E. A. Podrez Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI Blood, February 15, 2008; 111(4): 1962 - 1971. [Abstract] [Full Text] [PDF]

				P. Lykavieris, C. Crosnier, C. Trichet, M. Meunier-Rotival, and M. Hadchouel Bleeding Tendency in Children With Alagille Syndrome Pediatrics, January 1, 2003; 111(1): 167 - 170. [Abstract] [Full Text] [PDF]

				A. K. Stannard, D. R. Riddell, S. M. Sacre, A. D. Tagalakis, C. Langer, A. von Eckardstein, P. Cullen, T. Athanasopoulos, G. Dickson, and J. S. Owen Cell-derived Apolipoprotein E (ApoE) Particles Inhibit Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression in Human Endothelial Cells J. Biol. Chem., November 30, 2001; 276(49): 46011 - 46016. [Abstract] [Full Text] [PDF]

				D. R. Riddell, D. V. Vinogradov, A. K. Stannard, N. Chadwick, and J. S. Owen Identification and characterization of LRP8 (apoER2) in human blood platelets J. Lipid Res., October 1, 1999; 40(10): 1925 - 1930. [Abstract] [Full Text]

				C.-Y. Lin, H. Duan, and T. Mazzone Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E J. Lipid Res., September 1, 1999; 40(9): 1618 - 1627. [Abstract] [Full Text]

				A. H. Hasty, M. F. Linton, S. J. Brandt, V. R. Babaev, L. A. Gleaves, and S. Fazio Retroviral Gene Therapy in ApoE-Deficient Mice : ApoE Expression in the Artery Wall Reduces Early Foam Cell Lesion Formation Circulation, May 18, 1999; 99(19): 2571 - 2576. [Abstract] [Full Text] [PDF]

				C.-Y. Lin, M. Lucas, and T. Mazzone Endogenous apoE expression modulates HDL3 binding to macrophages J. Lipid Res., February 1, 1998; 39(2): 293 - 301. [Abstract] [Full Text]

				D. R. Riddell, A. Graham, and J. S. Owen Apolipoprotein E Inhibits Platelet Aggregation through the L-Arginine:Nitric Oxide Pathway. IMPLICATIONS FOR VASCULAR DISEASE J. Biol. Chem., January 3, 1997; 272(1): 89 - 95. [Abstract] [Full Text] [PDF]